COMP <GO>
LEVI vs AMZN // 10Y YIELD & FRED MACRO BETA
Levi Strauss & Co (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: LEVI 7
— AMZN 3
▲ 10Y YIELD & FRED MACRO BETA LEADER: AMZN
LAST: $22.61 (+4.53%) • MKT CAP: $8.67B
macro-sensitivity
1.10
LAST: $243.79 (-4.25%) • MKT CAP: $2.63T
macro-sensitivity
1.46
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LEVI VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LEVI | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.90% | 17.61% | +3.29 | LEVI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | 15.8x | -5.45 | LEVI | /valuation <GO> |
| Free Cash Flow Yield | 3.55% | -1.81% | +5.36 | LEVI | /fcf-yield <GO> |
| Operating Margin | 10.80% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 8.40% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 4.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.46% | 0.00% | +2.46 | LEVI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.97 | 3.32 | -0.35 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 6/9 | +3.00 | LEVI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.73% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.4 | 47.2 | +22.20 | LEVI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.10 | 1.46 | -0.36 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 22.8x | -7.45 | LEVI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.67B | $2.63T | -$2.62T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LEVI REV | AMZN REV | LEVI GROSS % | AMZN GROSS % | LEVI FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $6.28B | $0 | 61.7% | — | $308.2M | $10.56B |
| FY 2024 | $6.03B | $0 | 60.6% | — | $670.9M | $42.95B |
| FY 2023 | $5.84B | $0 | — | — | $172.6M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LEVI // BETA 1.10
AMZN // BETA 1.46